搜索结果: 1-7 共查到“医学 Hepatitis B Virus infection”相关记录7条 . 查询时间(0.078 秒)
The Prevalence of Hepatitis B Virus Infection in Mashhad, Iran:A Population-Based Study
Hepatitis B virus Prevalence
2015/9/29
Background: Hepatitis B virus (HBV) infection is the most common and serious liver infection in the world. An estimated 350 million people are chronic carriers of this virus, of whom, more than 620,00...
Intra-familial Transmission of Hepatitis B virus Infection in Zahedan
Carrier States Hepatitis B Transmission Iran Prevention and control HBV Seroprevalence
2015/9/29
Background: The household transmission of hepatitis B virus (HBV) is a major health problem. The prevalence rate of this infection is reported about 11% to 57% among family members of HBsAg carriers.
Efficacy of Influenza Vaccination in Patients with Cirrhosis and Inactive Carriers of Hepatitis B Virus Infection
Influenza Vaccination Cirrhosis Hepatitis B
2015/9/28
Background: Influenza can causes morbidity and mortality that are greatly enhanced in patients with underlying chronic diseases such as Cirrhotic patients. This study was performed to assess the immun...
Immunization of Rescuers against Hepatitis A Virus Infection in Disasterous Areas
Immunization Rescuers against Hepatitis Virus Infection Disasterous Areas
2015/9/21
Discussing the relevance of immunization of foreigner rescuers to Haiti people, in the recent disaster devastating this country, Ghorbani et al.1 in their Editorial have proposed that all rescuers nee...
Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
Hepatitis C virus Hemodialysis HCV genotypes Iran
2009/12/7
Background: To evaluate the prevalence of hepatitis C by antibody testing, HCV-RNA detection by PCR and relative risk factors of HCV infection among HD patients and staff members in Markazi Provi...
Occult Hepatitis B virus Infection among Anti-HBc only Positive Individuals in the Southeast of Iran in high prevalence of HBV Infection Region
Hepatitis B Virus infection HBV-DNA Anti-HBc Iran
2015/9/18
Background: The persistence of HBV-DNA in the serum of hepatitis B surface antigen negative individuals with or without the presence of HBV antibodies is termed occult HBV infection.
Investigation (In Vivo and In Vitro) of Booster Dose Vaccine Requirement for Long-Term Protection against Hepatitis B Virus Infection
HBV vaccination long-term protection booster dose requirement immunological memory
2009/5/20
Aim: Studies have shown that no booster dose was required at least 10 to 15 years after a primary vaccination for individuals who developed protective anti-hepatitis B surface (anti-HBs) antibodies. I...